Mini Podcast Series Episode 2: Rethinking "Next Generation" Drug Development Strategies

In episode 2 of our mini-podcast series "Through the Biotech Lens: Molecule to Market", our speakers David Cameron,  Senior Director and Global Head of Novel Trial Design and Lucas Glass,  Vice-President of Artificial Intelligence will discuss innovative trial designs that bring together the best of biopharma and technology to bring value to the patient.

Om Podcasten

The pace of change in healthcare is accelerating. Our understanding of how data, technology and scientific expertise can come together is only getting more precise. In this podcast, leaders from IQVIA lead discussions on the issues, innovations, and collaborations that are making an impact on health and business outcomes. Topics will include new approaches to clinical development, leading-edge technologies and methodologies that extract more value (and less work) from healthcare data, and strategies that ensure the right medicines get to the right patients, faster. IQVIA is a world leader in using data, technology, advanced analytics and expertise to help customers drive healthcare - and human health - forward.